Benztropine Mesylate Injection (Nexus Pharmaceuticals): Recall - Visible Particulate Matter
Risk of thromboembolism, some life-threatening (such as pulmonary emboli), as well as other serious adverse events.
Risk of thromboembolism, some life-threatening (such as pulmonary emboli), as well as other serious adverse events.
Events are rare but can be fatal.
Patients weighing more than 200 pounds and/or those with high levels of activity are at higher risk.
Sterile compounded products distributed nationwide
A false test result may lead to an insulin dosing error that could lead to a serious health risk requiring immediate medical attention.
Effects from use may include dizziness, loss of balance, ringing in the ears, feeling anxious, mistrustful, or depressed, or having hallucinations.
Facilities are instructed to cease use of their Nuclear Medicine system until a GE Engineer is able to do a complete inspection of the system
Nizoral tablets should be used only for the treatment of certain life-threatening mycoses when the potential benefits outweigh the risks, and alternative therapeutic options are not available or tolerated.
Using anabolic steroid-containing products may cause acute liver injury and some of the cases reported have
resulted in hospitalization.
L'Agenzia Europea dei Medicinali (EMA) ha terminato la revisione sulle terapie per il diabete a base di GLP-1. Il Comitato ha concluso che i dati attualmente disponibili non confermano le recenti preoccupazioni per un aumento del rischio di eventi avversi pancreatici con questi medicinali.
80.211.154.110